成田キャンパス

腎臓内科学教室

教室紹介

業績 2018年

英文論文

  1. Uchiyama K, Washida N, Muraoka K, Morimoto K, Kasai T, Yamaki K, Miyashita K, Wakino S, Itoh H. EXERCISE CAPACITY AND ASSOCIATION WITH QUALITY OF LIFE IN PERITONEAL DIALYSIS PATIENTS. Perit Dial Int 2018 Nov 25. pii: pdi.2018.00075. doi: 10.3747/pdi.2018.00075. [Epub ahead of print]
  2. Uchiyama K, Washida N, Yube N, Kasai T, Shinozuka K, Morimoto K, Hishikawa A, Inoue H, Urai H, Hagiwara A, Fujii K, Wakino S, Deenitchina S, Itoh H. Consumption in Simulated Patients on Automated Peritoneal Dialysis (APD) Using a Remote Monitoring System. Clin Nephrol 2018; 90(5):334-340.
  3. Washida N, Itoh H. Role of non-tuberculous mycobacteria in peritoneal dialysis-related infections: literature review, Contributions to Nephrology 2018;196:155-161. doi: 10.1159/000485716. Epub 2018 Jul 24.
  4. Fujii K, Washida N, Arai E, Tsuruta M, Wakino S, Itoh H.. Adhesive Intestinal Obstruction Increases the Risk of Intestinal Perforation in Peritoneal Dialysis Patients: Case Report. BMC nephrology 2018. 28;19:153. doi: 10.1186/s12882-018-0954-x.
  5. Kasai T, Washida N et al. Penile Calciphylaxis in a Patient on Combined Peritoneal Dialysis and Hemodialysis - A Case Report. CEN case report 2018; 7:204-207.
  6. Inoue H, Washida N, Morimoto K, Shinozuka K, Kasai T, Uchiyama K, Tokuyama H, Wakino S, Itoh H. Non-tuberculous mycobacterial infections related to peritoneal dialysis, Perit Dial Int 2018;38:147-149.
  7. Fujii K , Washida N, Tokuyama H, Yoshifuji A, Kasai T, Machida Y, Yoshida Y, Kameyama K, Wakino S, Hayashi M, Itoh H. Multinuclear and Ground Glass-formed Cells Detected in the Peritoneal Dialysate. Clin Infect Dis 2018; 67: 312-313.
  8. Mukai H, Svedberg O, Lindholm B, Dai L, Heimburger O, Barany P, et al. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study. Nephrol Dial Transplant. 2018.
  9. Mukai H, Ming P, Lindholm B, Heimburger O, Barany P, Stenvinkel P, et al. Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2018;43(2):522-35.
  10. Mukai H, Ming P, Lindholm B, Heimburger O, Barany P, Anderstam B, et al. Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease. PLoS One. 2018;13(4):e0195585.
  11. Mukai H, Villafuerte H, Qureshi AR, Lindholm B, Stenvinkel P. Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment. Semin Dial. 2018;31(5):435-9.
  12. Takenaka T, Ohno Y, Suzuki H. Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure. Diab Vasc Dis Res. 15: 154-157 2018
  13. Kurosaki Y, Imoto A, Kawakami F, Yokoba M, Takenaka T, Ichikawa T, Katagiri M, Ishii N. Oxidative stress increases megalin expression in the renal proximal tubules during the normoalbuminuric stage of diabetes mellitus. Am J Physiol Renal Physiol. 314. F462-F470: 2018

和文論文

  1. 鷲田直輝、葛西貴広、逆引き尿沈渣ガイド、Ⅴ 腎疾患、2.疾患の解説、⑥膜性腎症(MN)、医学書院「臨床検査」
  2. 内山清貴、鷲田直輝、【CQ12】被嚢性腹膜硬化症の発症予防の対策はどのように行いますか?「臨床透析」2018年6月増刊号(特集:透析医療におけるキュア&ケアガイドブック)
  3. 内山清貴、鷲田直輝、「カテーテルトラブル診療指針」2018年in press
  4. 内山清貴、鷲田直輝、「臨床検査法提要」第35版 第15章Ⅶ.4.腹膜透析2018年 in press
  5. 葛西貴広、鷲田直輝、腹膜透析治療において在宅医療はIT化がすすむ、「九州人工透析研究会誌」第3巻 in press
  6. 佐藤敦久.腎血管性高血圧のスクリーニングのポイントと管理.日本内科学会雑誌. 2018;4:703-712.
  7. 佐藤敦久、非ステロイド型MRAとはどのようなものでしょうか?.「心臓を守るミネラルコルチコイド受容体拮抗薬(MRA):その実力をQ&Aで解き明かす」. in press
  8. 佐藤敦久、MRAは腎不全で使いにくい印象があります。腎保護効果はあるのでしょうか。 「心臓を守るミネラルコルチコイド受容体拮抗薬(MRA):その実力をQ&Aで解き明かす」. in press
  9. 佐藤敦久、下垂体-副腎皮質機能検査. 臨床検査法概要 第8章内分泌代謝検査. in press